Back
to sessions
Sep 28
Science Highlights
SH 02 - Central Nervous System - Science Highlights
session DESCRIPTION
The following abstracts will be highlighted in this session:
- LBA 07 — Efficacy of Hypofractionated Stereotactic Radiotherapy with Different Dose Fractionation Regimens Combined with Concurrent Bevacizumab in Recurrent High-Grade Gliomas: A Randomized Controlled Trial — Feng Liu
- LBA 03 — Tumor Treating Fields (TTFields) After Stereotactic Radiosurgery (SRS) for Brain Metastases from Non-Small Cell Lung Cancer (NSCLC BM): Final Results of The Phase 3 METIS Trial — Vinai Gondi
- 101 — Phase II Prospective Trial of Image-Guided Cognitive-Sparing Brain Radiosurgery (COG-SRS) with a Connectivity Approach: The Future of Functional Preservation — Andrew Puett
- 103 — An Initial Report of Memory Avoidance Whole Brain Radiotherapy to Treat Brain Metastases: A Prospective Phase 2 Trial — Joshua Palmer
- 305 — Temporal Effects of Dose and Fractionation of FLASH and Conventional Irradiation on Hippocampal Neurogenesis and Mechanisms of FLASH-Induced Neuroprotection — Nikita Katila
- 100 — Multicenter, Phase 3 Randomized Trial of Stereotactic Radiation vs. Hippocampal Avoidance Whole Brain Radiation in Patients with 5-20 Brain Metastases: Recurrence, Salvage Therapy, and Mortality Endpoints — Ayal Aizer
Credits
| AMA PRA Category 1 Credits: | 0.50 |
| CAMPEP Credits: | 0.50 |
Presentations
-
08:00am - 08:30am PT
Discussant
Speaker: Jona Hattangadi-Gluth, MD, FASTRO - UC San Diego, La Jolla